Navigation Links
Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
Date:12/13/2007

-- Target diseases for this collaboration are Diffuse Large Cell Lymphoma,

Transformed Follicular Lymphoma, and Chronic Lymphocytic Leukemia

-- Collaboration to develop microRNA-based diagnostics test, early

detection and prognosis. -- 43,000 people will be diagnosed with these types of cancers in 2007 in

the US alone(1) -- MicroRNAs hold significant potential as highly sensitive and specific

biomarkers for hematological cancers -- Collaboration also will seek to identify microRNA (miRNA) targets for

therapeutic applications

REHOVOT, Israel and NEW YORK, Dec. 13 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (Nasdaq: ROSG) and Columbia University Medical Center announced today they will collaborate to develop microRNA-based diagnostic tests, early detection as well as prognosis, for Diffuse Large Cell Lymphoma, Transformed Follicular Lymphoma, and for Chronic Lymphocytic Leukemia. Three types of Non- Hodgkin Lymphoma (NHL).

"We are constantly expanding our pipeline with new diagnostic and therapeutic programs, both cancer and non-cancer related, in order to maximize our leading position in microRNA intellectual property and proprietary technologies", noted Amir Avniel, President and CEO of Rosetta Genomics. "We are very excited to be collaborating with a leading research institution such as Columbia University Medical Center, and hope more collaboration will follow."

Combining Rosetta Genomics know-how and proprietary technologies with Columbia University Medical Center's expertise in cancer, researchers will screen for microRNAs that may be used as potential biomarkers and drug targets for t
'/>"/>

SOURCE Rosetta Genomics
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
4. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
5. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
6. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
7. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
10. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
11. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., REYKJAVIK,Iceland,November24/PRNewswire-FirstCa...ncedthatithasreceivednoticefrom,theNasdaqStockMark...ndedasofNovember30,2009andaForm25-NSEwillbefiledwi...ovedeCODE,scommonstock,fromlistingonNasdaq,unlesst...tionsPanel.Thecompanyhasfiledsuchanappeal,which,wi...
(Date:11/24/2009)..., REYKJAVIK,Iceland,November24/PRNewswire-FirstCa...ncedtheapprovalofallofits,"firstday"motionsbytheU....kruptcyCourt").deCODElastweekfiledavoluntarypetiti...tcyCodewiththe,BankruptcyCourt. , Theordersis...tooperateitsbusinessduringtheChapter11proceedings....
(Date:11/24/2009)..., SHANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiola...tion(SFDA)hasapprovedthe,investigationalnewdrugapp...nnovativeinsulinformulationtotreatdiabetes.ThisIND...icalstudy. , Diabetesisadisordercharacteristi...ionsofdiabetesoftenresultinseveremicro-and,macro-v...
(Date:11/24/2009)... ,Primaryefficacyendpointhasbeenmetforpatientswit..., QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEterna...aglobalbiopharmaceuticalcompanyfocusedonendocrinet...tafromaPhase2studywithitstargetedcytotoxicpeptidec...vancedorrecurrentendometrialcancer.Inapersonalized...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
..., Inc. (OTC Bulletin Board: CSBR), a company engag...forms and tumor specific data to,enhance the value...tablished an agreement with ImClone Systems Incorp...herapeutic antibodies in ImClone,s,clinical develo...will,utilize Champions Biotechnology,s Biomerk Tum...
...daq: NGSX ), a biopharmaceutical company focused ...ement therapies, today announced it will,report re...15, 2008, before,the market opens., A conference ... ET,(6:00 a.m. PT) on May 15, 2008 and will be hos...ve Officer, and Stephen Ghiglieri, Chief,Financial...
...Biotech Ltd. (Amex: SVA ),a leading provider of v...,Yin, CEO, and Ms. Helen Yang, International Busin... Murray, Carret & Co. All-Cap All-China Conference...ndard Time at the Waldorf,Astoria in New York, NY....u, Senior Financial,Manager, are scheduled to pres...
Other Biology Technology:Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs 2Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs 3NeurogesX to Report First Quarter 2008 Financial Results 2NeurogesX to Report First Quarter 2008 Financial Results 3Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008 2
(Date:11/24/2009)...arteries from collapsing have been true life-saver...r needed -- once the arteries are strengthened, th...choice but to leave them in place. , Prof. Meita... Biomedical Engineering has developed a new patent...hey,re needed, then dissolves. , "Our new compos...
(Date:11/24/2009)...Medical Toxicology (ACMT) have signed an agreement... of Medical Toxicology (JMT), the official journa...eviously published by the University of Pennsylvan..., an international, peer-reviewed journal, is dedi...ical toxicology. The quarterly journal focuses on...
(Date:11/24/2009)...ld secrets of the earth,s history locked in its ic...little information on the environments that have b...ars. Now, a team of researchers from nine institut...of $10 million dollars by the National Science Fou...iterally. These scientists will drill through the ...
Breaking Biology News(10 mins):A coating for life 2Springer and the American College of Medical Toxicology to work together 2LSU gets to the bottom of things -- in Antarctica 2Crystal Heart Award Presented to Telemundo for Coverage of Organ Donation 50609 1Crystal Heart Award Presented to Telemundo for Coverage of Organ Donation 50609 2Research network wins approximately 26 23163 3B5 7 million to target human and animal diseases in Africa 9092 1Research network wins approximately 26 23163 3B5 7 million to target human and animal diseases in Africa 9092 2Research network wins approximately 26 23163 3B5 7 million to target human and animal diseases in Africa 9092 3Portico Healthnet Assumes Operation of 489 CARE Information and Referral Service 50603 1Portico Healthnet Assumes Operation of 489 CARE Information and Referral Service 50603 2
... the University of California at San Francisco (UC...dedicated to the brain that the controversy is ove...ain development are dead. , The cerebral cortex is... distinctly separate areas that process particular...what extent are these areas predetermined by genes...
...nd themselves by ejecting a potent inky secretion ...monia and several types of acids. A team of resear... Neuroscience (CBN) has found that this secretion ...eparately in two glands. The discovery, published ...xperimental Biology, provides insight into a natur...
...the antler of an Irish Elk in cliffs near Kirk Mic... of the antler has yet to be determined, the posit...eros giganteus) lived around 11,000 years ago. The...was widespread in northern Europe at the end of th...ds. , The students who found the elk were taking...
Other Biology News:MIT researcher presents new view of how the cortex forms 2Sea slug mixes chemical defense before firing at predators 2Students discover 11,000 year old remains of Irish Elk 2
Mouse Anti-Cystatin A Monoclonal Antibody, Unconjugated, Clone WR-23/2/3/3 from Sigma-Aldrich
...accato Application Series are a line of pre-integr... fast and reliable automated solutions to specific...tion-friendly" building blocks, Caliper has create...conventional approaches, take up little lab space ...
...has made microcapillary flow cytometry accessible ...l appreciate the latest addition to Guavas on-dema... use, surprising affordable, and very compact for ...em includes such features as absolute cell counts,...
...r, variable speed, timer, SB3, Fully adjustab..., Choice of tube holders to hold a number of dif...is ideal for aerating cultures, keeping biological...ications., The rotator can be used in incubat...
Biology Products: